Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guides

About the data

About CivixlyMethodologyData sources

Help improve Civixly

Send feedback or a correctionCommunity

State Government / California / Legislation / SB 1023

SB 1023Session 20252026SenateSent to governor

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally prohibits a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs that are medically necessary for the prevention of HIV/AIDS, including preexposure prophylaxis or postexposure prophylaxis, to prior authorization or step therapy. Under existing law, a health care service plan or health insurer is not required to cover all of the therapeutically equivalent versions of those drugs without prior authorization or step therapy if at least one is covered without prior authorization or step therapy. This bill would instead prohibit a health care service plan, excluding a Medi-Cal managed care plan, or health insurer from subjecting antiretroviral drugs, drug devices, or drug products that are medically necessary for the prevention of HIV/AIDS to prior authorization or step therapy. The bill would require, for a health care service plan contract or health insurance policy issued, amended, or renewed on or after January 1, 2027, a non-self-administered antiretroviral drug, drug device, or drug product that is approved by the United States Food and Drug Administration for the prevention of HIV/AIDS to be covered under both the plan or policy's medical benefit and prescription drug benefit, and if obtained under the plan or policy's drug benefit, would require the drug, device, or product to be dispensed and administered by a health care provider acting within the scope of their license. Because a willful violation of these provisions by a health care service plan would be a crime, this bill would impose a state-mandated local program. The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason.

Latest development · Aug 30, 2026

Enrolled and presented to the Governor at 6 p.m.

Your view
Source record ↗
Session
20252026
Introduced
Feb 10, 2026
Latest passage
Aug 24, 2026
TopicsSponsorsActionsRelated billsDiscussion

Topics and classification

Civixly topics

EducationHealthJustice & Public SafetyBusiness & Economy

Source subjects

Healthcarecoverageantiretroviraldrugs,drugdevices,anddrugproducts

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

Primary sponsorLaird
principal coauthorMark González

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline29 actions⌄
  1. Aug 30, 2026

    Enrolled and presented to the Governor at 6 p.m.

    Executive ReceiptCalifornia State Legislature
  2. Aug 25, 2026

    Assembly amendments concurred in. (Ayes 30. Noes 0.) Ordered to engrossing and enrolling.

    Amendment PassageCommittee PassageCommittee Passage FavorableSenate
  3. Aug 25, 2026

    Reconsideration granted. (Ayes 38. Noes 0.)

    Senate
  4. Aug 25, 2026

    Motion to reconsider made by Senator Ashby.

    Senate
  5. Aug 25, 2026

    Assembly amendments concurred in. (Ayes 31. Noes 1.) Ordered to engrossing and enrolling.

    Amendment PassageCommittee PassageCommittee Passage FavorableSenate
  6. Aug 24, 2026

    In Senate. Concurrence in Assembly amendments pending.

    Senate
  7. Aug 24, 2026

    Read third time. Passed. Ordered to the Senate.

    PassageReading 1Reading 3Assembly
  8. Aug 18, 2026

    Ordered to third reading.

    Reading 1Reading 3Assembly
  9. Aug 18, 2026

    Read third time and amended.

    Amendment PassageReading 1Reading 3Assembly
  10. Aug 13, 2026

    Read second time. Ordered to third reading.

    Reading 1Reading 2Reading 3Assembly
  11. Aug 13, 2026

    From committee: Do pass. (Ayes 11. Noes 1.) (August 13).

    Committee PassageCommittee Passage FavorableAssembly
  12. Aug 13, 2026

    Assembly Rule 63 suspended.

    Assembly
  13. Jul 1, 2026

    July 1 set for first hearing. Placed on suspense file.

    Assembly
  14. Jun 10, 2026

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 9). Re-referred to Com. on APPR.

    Committee PassageCommittee Passage FavorableReferral CommitteeAssembly
  15. May 26, 2026

    Referred to Com. on HEALTH.

    Referral CommitteeAssembly
  16. May 19, 2026

    In Assembly. Read first time. Held at Desk.

    Reading 1Assembly
  17. May 18, 2026

    Read third time. Passed. (Ayes 29. Noes 0. Page 4312.) Ordered to the Assembly.

    PassageReading 1Reading 3Senate
  18. May 14, 2026

    Read second time. Ordered to third reading.

    Reading 1Reading 2Reading 3Senate
  19. May 14, 2026

    From committee: Do pass. (Ayes 5. Noes 0. Page 4261.) (May 14).

    Committee PassageCommittee Passage FavorableSenate
  20. May 8, 2026

    Set for hearing May 14.

    Senate
  21. Apr 20, 2026

    April 20 hearing: Placed on APPR. suspense file.

    Senate
  22. Apr 10, 2026

    Set for hearing April 20.

    Senate
  23. Apr 9, 2026

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0. Page 3793.) (April 8). Re-referred to Com. on APPR.

    Committee PassageCommittee Passage FavorableReferral CommitteeSenate
  24. Mar 26, 2026

    Set for hearing April 8.

    Senate
  25. Mar 25, 2026

    Re-referred to Com. on HEALTH.

    Referral CommitteeSenate
  26. Mar 16, 2026

    From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS.

    Amendment PassageCommittee PassageReading 1Reading 2Referral CommitteeSenate
  27. Feb 18, 2026

    Referred to Com. on RLS.

    Referral CommitteeSenate
  28. Feb 11, 2026

    From printer. May be acted upon on or after March 13.

    Senate
  29. Feb 10, 2026

    Introduced. Read first time. To Com. on RLS. for assignment. To print.

    IntroductionReading 1Referral CommitteeSenate

Related California legislation

Other measures from this legislative session that share one or more Civixly topics with SB 1023.

AB 2179Updated Sep 10, 2026

Workplace violence: restraining orders.

Justice & Public Safety
SB 960Updated Sep 10, 2026

Public postsecondary education: community colleges: statewide baccalaureate degree program.

Education
AB 1159Updated Sep 10, 2026

Student personal information.

Education
AB 2770Updated Sep 10, 2026

State Property: San Pasqual Battlefield State Park.

Education
Browse all California legislation →

SB 1023 discussion

0 comments

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated Sep 10, 2026.